Period:
Draw Mode:
| Volume | 98,729 |
|
|||||
| News | - | ||||||
| Day High | 0.25 | Low High |
|||||
| Day Low | 0.235 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Altamira Therapeutics Ltd | CYTO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0149 | -5.96% | 0.235 | 14:18:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.2417 | 0.235 | 0.25 | 0.2499 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 241 | 98,729 | $ 0.2380501 | $ 23,502 | - | 0.22 - 13.52 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:21:17 | 1 | $ 0.24 | USD |
Altamira Therapeutics Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.64M | 6.99M | - | 306k | -26.53M | -3.80 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Altamira Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2402 | 0.26 | 0.22 | 0.2487001 | 115,022 | -0.0052 | -2.16% |
| 1 Month | 0.3483 | 0.41 | 0.22 | 0.2820272 | 611,649 | -0.1133 | -32.53% |
| 3 Months | 0.5652 | 0.6425 | 0.22 | 0.3639214 | 409,219 | -0.3302 | -58.42% |
| 6 Months | 1.28 | 2.60 | 0.22 | 1.24 | 1,400,390 | -1.05 | -81.64% |
| 1 Year | 5.68 | 13.52 | 0.22 | 3.89 | 1,294,523 | -5.45 | -95.86% |
| 3 Years | 58.60 | 77.40 | 0.22 | 22.30 | 1,427,590 | -58.37 | -99.6% |
| 5 Years | 58.60 | 77.40 | 0.22 | 22.30 | 1,427,590 | -58.37 | -99.6% |
Altamira Therapeutics Description
| Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. |